SPOCD1-AS pull-down assay in MeT-5A cells pre-treated with GIP showed that GIP reduced the endogenous SPOCD1-AS/G3BP1 binding (Fig. 7f), and inhibited the MMT phenotype and cancer cell adhesion to MeT-5A cells (Fig. 7 g, h and i). Here, SPOCD1 is linked to cancer.